Company intelligence / Profile preview

CITIC Group

Beijing, China

Ownership: Private
Development stage: Other

Overview

CITIC Group is a diversified state-owned conglomerate founded in 1979, operating in five business sectors: comprehensive financial services, advanced intelligent manufacturing, advanced materials, new consumption, and new-type urbanization. While primarily a financial and industrial conglomerate, it operates significant healthcare subsidiaries including CITIC Medical & Health and has investment arms (Trustar Capital, CITIC Capital) involved in pharmaceutical acquisitions and healthcare sector investments. Its healthcare subsidiaries have programs in development ranging from CAR-T cell therapy to vaccines and small molecules.

Therapeutic areas: OncologyEndocrinologyInfectious Diseases
Modalities: CAR-T cell therapyVaccineSmall molecule
Industry: Pharma

Partnerships

ItochuCharoen PokphandV-Capital

Beyond the preview

Go deeper on CITIC Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CITIC Group.

Explore the full profile